Dennerstein L. Well-being, symptoms and the menopausal transition. Maturitas 1996; 23: 147–157.
Utian WH. Overview on menopause. Am J Obstet Gynecol 1987; 156: 1280–1283.
Kauffert P. Women and their health in the middle years: A Manitoba project. Soc Sci Med 1984; 3: 279–281.
Greer G. The Change, Women, Ageing and the Menopause. London: Hamish Hamilton, 1991.
McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas 1992; 14: 103–115.
Dennerstein L, Smith AMA, Morse C, et al. Menopausal symptoms in Australian women. Med J Aust 1993; 159: 232–236.
Witt DM, Lousberg TR. Controversies surrounding estrogen use in postmenopausal women. Ann Pharmacother 1997; 31(6): 745–755.
Calaf I, Alsina J. Benefits of hormone replacement therapy-overview and update. Int J Fertil Women Med 1997; 42 (Suppl 2): 329–346.
Colditz GA. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J Nat Cancer I 1998; 90(11): 814–823.
Brown WJ, Bryson L, Byles JE, et al. Women's Health Australia: Establishment of the Australian Longitudinal Study on Women's Health. J Women's Health 1996; 5(5): 467–472.
Brown WJ, Mishra GD, Dobson AJ. Changes in physical symptoms during the menopause transition. Int J Behav Med (in press).
Kauffert PA, Gilbert P, Tate R. The Manitoba project: A re-examining of the link between menopause and depression. Maturitas 1992; 14: 143–156.
Avis N, Brambilla D, McKinlay SM, Vass K. A longitudinal analysis of the association between menopause and depression-results from the Massachusetts women's health study. Ann Epidemiol 1994; 4: 214–220.
Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston MA: The Health Institute, New England Medical Centre, 1994.
Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston MA: The Health Institute, New England Medical Centre, 1993.
Hemingway H, Stafford M, Stanfeld S, Shipley M, Marmot, M. Is the SF-36 a valid measure of change in population health? Results fromthe Whitehall II study. Br Med J 1997; 315(7118): 1273–1279.
Brown WJ, Bryson L, Byles JE, et al. Women's Health Australia: Recruitment for a national longitudinal cohort study. Women Health 1998; 28(1): 23–40.
McCallum J. The SF-36 in an Australian sample: Validating a new generic health status measure. Austr J Public Health 1995; 19: 160–166.
Dudley EC, Hopper JL, Taffe J, Guthrie JR, Burger HG, Dennerstein L. Using longitudinal data to define the perimenopause by menstrual cycle characteristics. Climacteric 1998; 1: 18–25.
Brown WJ, Lee C, Mishra G, Bauman A. Leisure time physical activity in Australian women: Relationship with well-being and symptoms. Res Q Exercise Sport 2000; 71: 206–216.
Department of Primary Industries and Energy, Department of Human Services and Health. Rural, Remote and Metropolitan Areas Classification: 1991 Census Edition. Canberra: Australian Government Publishing Service, 1994.
SAS Institute Inc. SAS/STAT User's Guide, Version 6, 4th ed, Vol 2. Cary, NC: SAS Institute Inc., 1989.
National Health Survey Australia, 1995: SF-36 Population Norms. National Health Survey. Canberra: Australian Bureau of Statistics, 1997.
Brown WJ, Dobson AJ, Mishra G. What is a healthy weight for middle-aged women? Int J Obesity 1998; 22: 520–528.
Guthrie JR, Dudley EC, Dennerstein L, Hopper JL. Changes in physical activity and health outcomes in a population-based cohort of mid-life Australian-born women. Aust J Public Health 1997; 21(7): 682–687.
McKinlay JB, McKinlay SM, Brambilla D. The relative contributions of endocrine changes and social circumstances to depression in mid-aged women. J Health Soc Behav 1987; 28: 345–363.